Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07525635) titled 'Aspirin Dosing in Pregnancy' on April 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: NYU Langone Health

Condition: Preeclampsia Possible

Intervention: Drug: Aspirin

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of First Enrollment: April 15, 2026

Target Sample Size: 30

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07525635

Published by HT Digital Content Services with permission from Health Daily Digest....